Cymal-6

• UNSPSC Description:

  Cymal-6 (Cyclohexyl-hexyl-β-D-maltoside) is a potent TEM-1 beta-lactamase inhibitor with an Ki value of 40.05 µM. Cymal-6 (Cyclohexyl-hexyl-β-D-maltoside) can be used as glycosidic surfactant[1][2].

• Target Antigen:

  Bacterial

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/cymal-6.html

• Solubility:

  DMSO : 250 mg/mL (ultrasonic)

• Smiles:

  OC[C@@H](O[C@H]([C@@H]([C@H]1O)O)OCCCCCCC2CCCCC2)[C@H]1O[C@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)CO

• Molecular Weight:

  508.60

• References & Citations:

  [1]Avci FG, et al. Targeting a hidden site on class A beta-lactamases. J Mol Graph Model. 2018 Sep;84:125-133. |[2]Ju M, et al. Enantioseparations by capillary electrophoresis using chiral glycosidic surfactants. II. Comparisonof chiral cyclohexyl-alkyl-β-D-maltoside surfactant. Journal of Liquid Chromatography & Related Technologies. 2000, 23(1):35-45.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  228579-27-9